Trial intelligence / Profile preview

Antibiotic irrigation in ventral hernia repair

NCT03945357Phase 3Completed

Sponsor
Prisma Health
Start
May 2019
Primary completion
Jan 2023
Modality
Nanoparticles, Implantable Devices, Transdermal Patches
Countries
1
01

Overview

Phase 3, randomised, triple-blind trial of gentamicin and clindamycin in surgical site infection (SSI), sponsored by Prisma Health. Primary endpoint: Surgical Site Infection at 30 days. Started May 2019; status: completed.

02

Drugs

gentamicinclindamycin
03

Conditions

surgical site infection (SSI)

Beyond the preview

Go deeper on NCT03945357.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT03945357.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call